STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation - Chengfei Zhang; Ping Xu; Yongsheng Wang; Xin Chen; Yue Pan; Zhijie Ma; Cheng Wang; Haojun Xu; Guoren Zhou; Feng Zhu; Hongping Xia (Acta Pharmaceutica Sinica B, 2025)